Private Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $493M | Buy |
411,425
+5,470
| +1% | +$5.59M | 43.24% | 1 |
|
|
2026
Q1 | $373M | Sell |
405,955
-21,548
| -5% | -$21.8M | 42.82% | 1 |
|
|
2025
Q4 | $459M | Sell |
427,503
-6,132
| -1% | -$5.86M | 46.91% | 1 |
|
|
2025
Q3 | $331M | Buy |
433,635
+313
| +0.1% | +$233K | 36.82% | 1 |
|
|
2025
Q2 | $338M | Sell |
433,322
-458
| -0.1% | -$356K | 41.15% | 1 |
|
|
2025
Q1 | $358M | Sell |
433,780
-75
| -0% | -$62.4K | 42.84% | 1 |
|
|
2024
Q4 | $335M | Buy |
433,855
+548
| +0.1% | +$454K | 39.87% | 1 |
|
|
2024
Q3 | $384M | Hold |
433,307
| – | – | 42.04% | 1 |
|
|
2024
Q2 | $392M | Buy |
433,307
+3,293
| +0.8% | +$2.63M | 43.69% | 1 |
|
|
2024
Q1 | $335M | Buy |
430,014
+8,927
| +2% | +$6.35M | 41.66% | 1 |
|
|
2023
Q4 | $245M | Sell |
421,087
-44,161
| -9% | -$25.8M | 37.4% | 1 |
|
|
2023
Q3 | $258M | Buy |
465,248
+5,411
| +1% | +$2.79M | 39.75% | 1 |
|
|
2023
Q2 | $216M | Buy |
459,837
+12,088
| +3% | +$5.07M | 35.37% | 1 |
|
|
2023
Q1 | $154M | Buy |
447,749
+70
| +0% | +$23.6K | 28.98% | 1 |
|
|
2022
Q4 | $164M | Buy |
447,679
+7,016
| +2% | +$2.49M | 28.08% | 1 |
|
|
2022
Q3 | $142M | Hold |
440,663
| – | – | 24.71% | 1 |
|
|
2022
Q2 | $143M | Buy |
440,663
+8,155
| +2% | +$2.45M | 24.07% | 1 |
|
|
2022
Q1 | $124M | Buy |
432,508
+2,567
| +0.6% | +$661K | 18.04% | 1 |
|
|
2021
Q4 | $119M | Buy |
429,941
+15,465
| +4% | +$3.92M | 18.95% | 1 |
|
|
2021
Q3 | $95.8M | Buy |
414,476
+8,657
| +2% | +$2.14M | 15.95% | 1 |
|
|
2021
Q2 | $93.1M | Buy |
405,819
+35,055
| +9% | +$7.04M | 15.76% | 1 |
|
|
2021
Q1 | $69.3M | Hold |
370,764
| – | – | 12.94% | 1 |
|
|
2020
Q4 | $62.6M | Buy |
370,764
+36,040
| +11% | +$5.38M | 12.63% | 1 |
|
|
2020
Q3 | $49.5M | Hold |
334,724
| – | – | 11.51% | 1 |
|
|
2020
Q2 | $55M | Sell |
334,724
-1,000
| -0.3% | -$153K | 14.24% | 1 |
|
|
2020
Q1 | $46.6M | Buy |
335,724
+175
| +0.1% | +$24K | 14.75% | 1 |
|
|
2019
Q4 | $44.1M | Hold |
335,549
| – | – | 10.81% | 1 |
|
|
2019
Q3 | $37.5M | Buy |
335,549
+50,000
| +18% | +$5.57M | 10.43% | 1 |
|
|
2019
Q2 | $31.6M | Hold |
285,549
| – | – | 8.95% | 1 |
|
|
2019
Q1 | $37.1M | Hold |
285,549
| – | – | 11.21% | 1 |
|
|
2018
Q4 | $33M | Hold |
285,549
| – | – | 11.85% | 1 |
|
|
2018
Q3 | $30.6M | Sell |
285,549
-100,000
| -26% | -$10M | 8.46% | 1 |
|
|
2018
Q2 | $32.9M | Hold |
385,549
| – | – | 10.31% | 1 |
|
|
2018
Q1 | $29.8M | Hold |
385,549
| – | – | 9.94% | 1 |
|
|
2017
Q4 | $32.6M | Sell |
385,549
-2,990
| -0.8% | -$254K | 11.31% | 1 |
|
|
2017
Q3 | $33.2M | Buy |
388,539
+9,205
| +2% | +$755K | 11.34% | 1 |
|
|
2017
Q2 | $31.2M | Sell |
379,334
-5,230
| -1% | -$427K | 10.09% | 1 |
|
|
2017
Q1 | $32.3M | Buy |
384,564
+34,141
| +10% | +$2.73M | 10.55% | 1 |
|
|
2016
Q4 | $25.8M | Sell |
350,423
-11,925
| -3% | -$888K | 8.82% | 1 |
|
|
2016
Q3 | $29.1M | Hold |
362,348
| – | – | 10.37% | 1 |
|
|
2016
Q2 | $28.5M | Buy |
+362,348
| New | +$27.3M | 10.77% | 1 |
|
Other funds holding LLY
SC
ONB
GIM
Private Capital Advisors's LLY Position: Q2 2026 in Review
Private Capital Advisors increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $5.59M and bringing the position to 411,425 shares worth $493M. The position accounts for 43.24% of the portfolio, ranked #1.
Private Capital Advisors first reported a position in LLY in Q2 2016 and has held it in 41 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Private Capital Advisors held 411,425 shares of Eli Lilly worth $493M as of Q2 2026.
- Private Capital Advisors bought 5,470 Eli Lilly shares in Q2 2026, an estimated $5.59M.
- Eli Lilly made up 43.24% of Private Capital Advisors's portfolio in Q2 2026, its #1 holding.
- Private Capital Advisors first reported a position in Eli Lilly in Q2 2016 and has held it in 41 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Private Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.